What it is
Akkermansia muciniphila is a next-generation probiotic strain available in capsule form. It is specifically used to support metabolic and blood-sugar health by enhancing gut lining integrity.
Supplement · Probiotic
Akkermansia muciniphila
5 billion CFU · vegan · gluten-free · 30 caps
insulin resistanceweight-gainfatigue pancreaslivermuscle
Affiliate link · we earn from qualifying purchases. No paid placements.
How it works
This probiotic works by strengthening the gut barrier, which in turn influences the pancreas, liver, and muscle tissue. Its effects on metabolic markers are typically observed within 8-12 weeks of consistent daily use.
Who should take it
Adults looking to address insulin resistance, weight gain, low energy. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
Avoid / careful
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
When to take it
Morning
Noon
Evening
Night
How to take it
With food
Empty stomach
Before food
FAQs
Frequently asked
How long does it take to see results?
Metabolic markers typically show measurable improvements within 8-12 weeks of consistent daily use.
Can Akkermansia be taken with other supplements?
Yes, it can be layered into a broader protocol. However, consult a clinician if you are on prescription medication affecting similar pathways.
What is the primary benefit of Akkermansia?
Its primary benefit lies in strengthening the gut lining, which positively impacts glucose metabolism and insulin sensitivity.
Research
6 studies · 2010–2024
Evidence grade
ABCD
C · C · emerging-to-moderate human evidence for metabolic and blood-sugar health
From the blog
Editorial notes
SacredBod's longer take on Akkermansia muciniphila — context the structured blocks above don't capture.
About Akkermansia muciniphila
Akkermansia muciniphila is a probiotic supplement used to support metabolic and blood-sugar health. Next-gen strain for gut lining and metabolism. It is available in capsule form and dosed for adults in India and internationally. As a western-tradition entry in the SacredBod catalog, it is positioned as a single-ingredient option that can be used on its own or layered into a broader protocol. Akkermansia muciniphila works through the mechanisms characteristic of its class — see the mechanism and research sections for detail. It primarily acts on the pancreas, liver, muscle, and effects are dose-dependent, typically becoming measurable within 8-12 weeks for metabolic markers. Consistency matters more than dose size for this category.
Evidence
Akkermansia muciniphila carries an evidence grade of C in the SacredBod catalog, reflecting emerging human evidence for metabolic and blood-sugar health. Next-gen strain for gut lining and metabolism. Benefits are cumulative rather than immediate, typically becoming noticeable within 8-12 weeks for metabolic markers, and individual response varies.
Dosing
A typical dose is 5 billion CFU, taken with food, usually in the morning. Start at the lower end, assess tolerance, and stay consistent; more is not automatically better.
Cautions
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
Who it’s for
Adults looking to address insulin resistance, weight gain, low energy. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
As part of the Probiotic category, Akkermansia muciniphila can be used on its own or layered into a broader protocol — see the Goes with panel for evidence-aligned pairings.
Added to your stack.